Activated lymphocytes and high liver expression of IFN-γ are associated with fulminant hepatic failure in patients

Liver International

Volumn 32, Issue 1, 2012, Pages 147-157

  dos Santos, Damião C M ^a   Neves, Patricia C C ^b   Azeredo, Elzinandes L ^a   Pelajo Machado, Marcelo ^a   Martinho, José Manoel S G ^c   Pacheco Moreira, Lúcio F ^c   Araújo, Cristina C V ^c   Cruz, Oswaldo Gonçalves ^a   de Oliveira, Jaqueline Mendes ^a   Pinto, Marcelo Alves ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

^c Hospital Federal de Bonsucesso   (Brazil)

Author keywords

Cytokines; Fulminant hepatic failure; Lymphocyte markers

Indexed keywords

BETA1 INTEGRIN; CD38 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FULMINANT HEPATIC FAILURE; HEPATITIS B; HUMAN; IMMUNOFLUORESCENCE; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER; LIVER FAILURE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PROGNOSIS; TISSUE DONORS; YOUNG ADULT;

EID: 83255162070     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02654.x     Document Type: Article

References (48)

1. Vaquero J, Blei AT. Etiology and management of fulminant hepatic failure. Curr Gastroenterol Rep 2003; 5: 39-47.
2. Leifeld L, Cheng S, Ramakers J, et al. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 2002; 36: 1001-8.
3. Miyakawa R, Ichida T, Yamagiwa S, et al. Hepatic natural killer and natural killer T cells markedly decreased in two cases of drug-induced fulminant hepatic failure rescued by living donor liver transplantation. J Gastroenterol Hepatol 2005; 20: 1126-30.
4. Shimamura K, Kawamura H, Nagura T, et al. Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell Immunol 2005; 234: 31-8.
5. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009; 6: 15-25.
6. Clayberger C. Cytolytic molecules in rejection. Curr Opin Organ Transplant 2009; 14: 30-3.
7. Lanier LL. Natural killer cells: roundup. Immunol Rev 2006; 214: 5-8.
8. Dunn C, Peppa D, Khanna P, et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137: 1289-300.
9. Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010; 6: e1001227.
10. Notas G, Kisseleva T, Brenner D. NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009; 130: 16-26.
11. Billerbeck E, Bottler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007; 13: 4858-64.
12. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007; 85: 16-23.
13. Kimura K, Ando K, Tomita E, et al. Elevated intracellular IFN-gamma levels in circulating CD8 + lymphocytes in patients with fulminant hepatitis. J Hepatol 1999; 31: 579-83.
14. Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 1541-54.
15. Tan AT, Koh S, Goh W, et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010; 52: 330-9.
16. Kakimi K, Lane TE, Wieland S, et al. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 2001; 194: 1755-66.
17. Kagami S, Kondo S. Beta1-integrins and glomerular injury. J Med Invest 2004; 51: 1-13.
18. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-21.
19. Sandalova E, Laccabue D, Boni C, et al. Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans. PLoS Pathog 2010; 6: e1001051.
20. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol 1999; 52: 189-96.
21. Kimura K, Nagaki M, Kakimi K, et al. Critical role of CD44 in hepatotoxin-mediated liver injury. J Hepatol 2008; 48: 952-61.
22. Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999; 21: 565-82.
23. Vega-Ramos J, Alari-Pahissa E, Valle JD, et al. CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection. Immunol Cell Biol 2010; 88: 707-15.
24. Sconocchia G, Titus JA, Mazzoni A, et al. CD38 triggers cytotoxic responses in activated human natural killer cells. Blood 1999; 94: 3864-71.
25. Lima M, Almeida J, dos Anjos Teixeira M, et al. The "ex vivo" patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states. Blood Cells Mol Dis 2002; 28: 181-90.
26. Gu LL, Xu B, Zhang JY, Zhang Z, Wang FS. [Dynamic expression of PD-1 in HBV-specific cytotoxic T lymphocytes correlates with memory T-cell development in acute hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi 2008; 16: 649-53.
27. Thimme R, Oldach D, Chang KM, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 1395-406.
28. Chen D, McKallip RJ, Zeytun A, et al. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol 2001; 166: 5889-97.
29. McKallip RJ, Fisher M, Gunthert U, et al. Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage. Infect Immun 2005; 73: 50-61.
30. Kimura K, Nagaki M, Saio M, Moriwaki H, Kakimi K. Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice. J Gastroenterol 2009; 44: 218-27.
31. Kimura K, Nagaki M, Matsuura T, Moriwaki H, Kakimi K. Pathological role of CD44 on NKT cells in carbon tetrachloride-mediated liver injury. Hepatol Res 2009; 39: 93-105.
32. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, et al. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol 2006; 143: 345-56.
33. Sixt M, Bauer M, Lammermann T, Fassler R. Beta1 integrins: zip codes and signaling relay for blood cells. Curr Opin Cell Biol 2006; 18: 482-90.
34. Albarran B, Goncalves L, Salmen S, et al. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. Apmis 2005; 113: 526-35.
35. Ito H, Ando K, Nakayama T, et al. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 2003; 38: 1116-24.
36. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004; 127: 1525-39.
37. dos Santos DC, da Silva Gomes Martinho JM, Pacheco-Moreira LF, et al. Eosinophils involved in fulminant hepatic failure are associated with high interleukin-6 expression and absence of interleukin-5 in liver and peripheral blood. Liver Int 2009; 29: 544-51.
38. Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 2010; 34: 45-54.
39. Mita A, Hashikura Y, Tagawa Y, et al. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Am J Gastroenterol 2005; 100: 2551-9.
40. Topham NJ, Hewitt EW. Natural killer cell cytotoxicity: how do they pull the trigger?Immunology 2009; 128: 7-15.
41. Huang YS, Chan CY, Wu JC, et al. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 1996; 24: 377-84.
42. Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-6.
43. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993; 18: 576-80.
44. Shimoda K, Begum NA, Shibuta K, et al. Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 1998; 28: 108-15.
45. Rowell DL, Eckmann L, Dwinell MB, et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 1997; 273: G322-32.
46. Saravanabalaji S, Tripathy AS, Dhoot RR, et al. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e. Intervirology 2009; 52: 78-85.
47. Yumoto E, Higashi T, Nouso K, et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002; 17: 285-94.
48. Wu Z, Han M, Chen T, Yan W, Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 2010; 30: 782-94.